We’ll see more of these testimonials as Remplir is used across new regions including the U.S. The fact that this surgeon went out his way after performing complex surgery on that day to write about his positive experience with Remplir and, with just one use, plans to change decades old sutures method for nerve repair speaks volumes about Remplir. He’s promoted this on his socials (3600+ followers) and others have too. No doubt he is telling his peers. As the number of surgeons using Remplir increase, we’ll likely see a network effect of testimonials like these that will supercharge sales.
The surgeon’s comments are consistent with what Paul said in an interview about how he has seen surgeons react to first handling Remplir in their hands. They love it.
It is these little additional anecdotal information that retail shareholders can obtain to know well ahead of others that Remplir and Orthocell is destined to very successful.
OCC Price at posting:
$1.34 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)